New SUSTAIN-6 Data Could Explain Retinopathy Worsening

Patients who developed retinopathy complications with semaglutide were more likely to have had preexisting retinopathy, poorer baseline glycemic control, and more robust glucose lowering in the trial.
Medscape Medical News

Full Story →